ask="N/A"
ask_size="N/A"
average_daily_volume="9685"
bid="1.0400"
bid_size="500"
book_value="0.8430"
change="+0.0001"
change_from_200_day_moving_average="-1.1370"
change_from_50_day_moving_average="-0.6072"
change_from_52_week_high="-3.5199"
change_From_52_week_low="0.3401"
change_in_percent="+0.0058%"
close="1.7301"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.4560"
ebitda="-14.29M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.0700"
eps_estimate_next_year="-0.3300"
ex_dividend_date="N/A"
float_shares="25678000"
high="1.7301"
high_52_weeks="5.2500"
last_trade_date="3/15/2017"
last_trade_price="1.7301"
last_trade_size="200"
last_trade_time="3:35pm"
low="1.6500"
low_52_weeks="1.3900"
market_capitalization="68.65M"
moving_average_200_day="2.8671"
moving_average_50_day="2.3373"
name="Oasmia Pharmaceutical AB"
notes="N/A"
one_year_target_price="N/A"
open="1.6500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-39.6568%"
percent_change_from_50_day_moving_average="-25.9800%"
percent_change_from_52_week_high="-67.0457%"
percent_change_from_52_week_low="+24.4676%"
previous_close="1.7300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.0522"
price_per_sales="84.5196"
revenue="812175.00"
shares_outstanding="39679000"
short_ratio="0.6100"
stock_exchange="NCM"
symbol="OASM"
volume="650"
weeks_range_52="1.3900 - 5.2500"
